封面
市場調查報告書
商品編碼
1577280

木脂素市場、機會、成長動力、產業趨勢分析與預測,2024-2032

Lignans Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球木脂素市場估值為 770.3 億美元,2024 年至 2032 年將以 5.8% 的複合年成長率成長。這些植物化學物質以其抗氧化和抗發炎特性而聞名,在營養保健品和功能性食品領域中佔有一席之地。

對天然和有機成分的需求正在上升,研究強調了木脂素在疾病預防和管理方面的潛力,特別是在荷爾蒙相關疾病方面的潛力,進一步推動了這種需求。根據全球健康研究所的報告,2017年至2022年,健康經濟每年成長6.4%,凸顯了消費者對健康的日益關注。

隨著消費者優先考慮健康和保健,木酚素產業正在經歷顯著成長。這種上升主要是由於人們對天然補充劑和功能性食品的興趣日益濃厚,特別是那些富含木脂素的食品,這些食品因其心血管和荷爾蒙平衡的益處而受到讚譽。此外,萃取方法的進步正在提高木脂素產品的純度和功效,監管部門的批准和科學驗證進一步證實了這一事實。例如,2023 年《食品科學與技術期刊》上發表的一項研究強調了萃取技術的改進可提高木酚素的生物利用度。

整個木脂素產業根據來源、應用和地區進行分類。

市場將來源分為油籽、穀物、植物樹脂。到 2032 年,以油籽為基礎的細分市場預計將達到 1,071.1 億美元,複合年成長率為 5.9%。油籽,特別是亞麻籽、芝麻籽和葵花籽,因其木酚素含量高和生物利用度高而在市場上佔據主導地位。這些化合物以其抗氧化和抗發炎特性而聞名,廣泛應用於食品、補充劑和營養保健品中,推動了油料種子的龐大市場佔有率。

應用領域分為化妝品、動物飼料、藥品和食品。食品領域佔了50%的市場佔有率,相當於151.9億美元。預測顯示,從2024 年到2032 年,複合年成長率為5.7%。具有雌激素和抗氧化特性。

亞太地區木脂素市場預計將達到425.8 億美元,預計2024 年至2032 年複合年成長率為5.4%。風險和促進健康的潛力。中國、日本和印度等國家正在引領這一向天然和有機補充劑的轉變,鞏固了該地區的主導地位。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
    • 主要製造商
    • 經銷商
    • 全行業利潤率
  • 產業影響力
    • 成長動力
      • 北美日益成長的健康問題
      • 歐洲強大的製藥業
      • 亞太地區不斷成長的動物飼料產業
    • 市場挑戰
      • 缺乏產品意識
      • 監管變化
    • 市場機會
      • 新機遇
      • 成長潛力分析
  • 原料景觀
    • 製造趨勢
    • 技術演進
      • 永續製造
        • 綠色實踐
        • 脫碳
    • 原料的永續性
    • 價格趨勢(美元/噸),2021 - 2032
  • 法規和市場影響
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場規模與預測:按來源分類,2021-2032 年

  • 主要趨勢
  • 油籽
  • 穀物
  • 植物樹脂

第 6 章:市場規模與預測:按應用分類,2021-2032 年

  • 主要趨勢
  • 食物
  • 化妝品
    • 皮膚護理
    • 頭髮護理
    • 化妝品
    • 其他
  • 動物飼料
    • 反芻動物
    • 馬匹
    • 其他
  • 藥品
    • 雌激素相關的健康疾病
    • 心血管疾病
    • 其他

第 7 章:市場規模與預測:按地區分類,2021-2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • MEA
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • MEA 的其餘部分

第 8 章:公司簡介

  • Henkel
  • TSKG
  • Natural Ingredient Bio-Resources
  • Prairie Tide Diversified
  • Biogin
  • Shaanxi Zebrago Industrial
  • Xian Lyphar Biotech
  • Natural Ingredient Bio-Resources, Limited
  • Dongguan Meiherb Biotech
  • VNI bioscience
  • Zebrago Herb
  • Hunan NutraMax
  • Kingherbs Hanzhong Penghong Tianyi Biotech Co., Ltd
  • Naturalin Bio-Resources Co., Ltd.
  • Ningbo United Plant Technology Co., Ltd.
  • Hebei Xinqidian Biotechnology Co., Ltd.
  • Skuny Bioscience Co., Ltd.
  • Shaanxi Sinuote Biotech Co., Ltd.
  • Xi'an Qingshuo Import and Export Trade Co., Ltd
  • Wuxi Gorunjie Natural-Pharma Co., Ltd
  • Xi'an Contri Biological Technology Co., Ltd
  • Hangzhou Excelente
  • Beijing UE Biotech Co., Ltd
  • FarmaSino Pharmaceuticals
簡介目錄
Product Code: 4594

The Global Lignans Market was valued at USD 77.03 billion and will grow at 5.8% CAGR from 2024 to 2032. The robust growth is largely attributed to increasing consumer awareness of health and wellness benefits. Celebrated for their antioxidant and anti-inflammatory properties, these phytochemicals are carving a niche in the nutraceutical and functional food sectors.

Demand for natural and organic ingredients is on the rise, further propelled by research highlighting lignans' potential in disease prevention and management, particularly for hormone-related ailments. According to a report by the Global Wellness Institute, the wellness economy grew by 6.4% annually from 2017 to 2022, underscoring the increasing consumer focus on health.

With consumers prioritizing health and wellness, the lignans industry is experiencing notable growth. This uptick is primarily driven by a heightened interest in natural supplements and functional foods, especially those rich in lignans, which are lauded for their cardiovascular and hormone-balancing benefits. Furthermore, advancements in extraction methods are boosting the purity and efficacy of lignan products, a fact that's being reinforced by regulatory approvals and scientific validation. For instance, a study published in the Journal of Food Science and Technology in 2023 highlighted the improved extraction techniques that enhance lignan bioavailability.

The overall lignans Industry is categorized based on source, application, and region.

The market categorizes source into oilseeds, cereals, plant resins. The oil seeds-based segment is set to reach USD 107.11 billion by 2032, showcasing a 5.9% CAGR. Oil seeds, particularly flaxseeds, sesame seeds, and sunflower seeds, dominate the market due to their high lignan content and bioavailability. Celebrated for their antioxidant and anti-inflammatory properties, these compounds find extensive use in food products, supplements, and nutraceuticals, driving the substantial market share of oil seeds.

The application segment is categorized into cosmetics, animal feed, pharmaceuticals and food. The food segment accounted for 50% of the market share, translating to USD 15.19 billion. Projections indicate a growth rate of 5.7% CAGR from 2024 to 2032. Lignans are integral to a variety of food items, including pasta, cereals, whole grain breads, energy bars, crackers, snack foods, and meatless products, imparting estrogenic and antioxidant properties.

Asia Pacific lignans market is on track to reach USD 42.58 billion, with a projected CAGR of 5.4% from 2024 to 2032. This growth is fuelled by rising consumer awareness of lignans' health benefits, such as their potential to reduce chronic disease risks and promote overall wellness. Countries like China, Japan, and India are leading this shift towards natural and organic supplements, solidifying the region's prominence.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Base estimates and calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Key manufacturers
    • 3.1.2 Distributors
    • 3.1.3 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 North America Growing health concerns
      • 3.2.1.2 Europe Strong pharmaceutical sector
      • 3.2.1.3 Asia Pacific Growing animal feed industry
    • 3.2.2 Market challenges
      • 3.2.2.1 Lack of product awareness
      • 3.2.2.2 Regulatory Variability
    • 3.2.3 Market opportunity
      • 3.2.3.1 New opportunities
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
    • 3.3.2 Technology evolution
      • 3.3.2.1 Sustainable manufacturing
        • 3.3.2.1.1 Green practices
        • 3.3.2.1.2 Decarbonization
    • 3.3.3 Sustainability in raw materials
    • 3.3.4 Pricing trends (USD/Tons), 2021 - 2032
      • 3.3.4.1 North America
      • 3.3.4.2 Europe
      • 3.3.4.3 Asia Pacific
      • 3.3.4.4 Latin America
      • 3.3.4.5 Middle East and Africa
  • 3.4 Regulations and market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Tons)

  • 5.1 Key trends
  • 5.2 Oilseeds
  • 5.3 Cereals
  • 5.4 Plant resins

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

  • 6.1 Key trends
  • 6.2 Food
  • 6.3 Cosmetics
    • 6.3.1 Skin Care
    • 6.3.2 Hair care
    • 6.3.3 Toiletries
    • 6.3.4 Others
  • 6.4 Animal Feed
    • 6.4.1 Ruminants
    • 6.4.2 Horses
    • 6.4.3 Others
  • 6.5 Pharmaceuticals
    • 6.5.1 Estrogen related health diseases
    • 6.5.2 Cardiovascular disease
    • 6.5.3 Others

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 MEA
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 South Africa
    • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

  • 8.1 Henkel
  • 8.2 TSKG
  • 8.3 Natural Ingredient Bio-Resources
  • 8.4 Prairie Tide Diversified
  • 8.5 Biogin
  • 8.6 Shaanxi Zebrago Industrial
  • 8.7 Xian Lyphar Biotech
  • 8.8 Natural Ingredient Bio-Resources, Limited
  • 8.9 Dongguan Meiherb Biotech
  • 8.10 VNI bioscience
  • 8.11 Zebrago Herb
  • 8.12 Hunan NutraMax
  • 8.13 Kingherbs Hanzhong Penghong Tianyi Biotech Co., Ltd
  • 8.14 Naturalin Bio-Resources Co., Ltd.
  • 8.15 Ningbo United Plant Technology Co., Ltd.
  • 8.16 Hebei Xinqidian Biotechnology Co., Ltd.
  • 8.17 Skuny Bioscience Co., Ltd.
  • 8.18 Shaanxi Sinuote Biotech Co., Ltd.
  • 8.19 Xi'an Qingshuo Import and Export Trade Co., Ltd
  • 8.20 Wuxi Gorunjie Natural-Pharma Co., Ltd
  • 8.21 Xi'an Contri Biological Technology Co., Ltd
  • 8.22 Hangzhou Excelente
  • 8.23 Beijing UE Biotech Co., Ltd
  • 8.24 FarmaSino Pharmaceuticals